NPS PHARMACEUTICALS INC 4
4 · NPS PHARMACEUTICALS INC · Filed Dec 26, 2013
Insider Transaction Report
Form 4
GRONINGER JAMES G
Director
Transactions
- Sale
Common Stock
2013-12-23$29.50/sh−3,000$88,500→ 750 total - Exercise/Conversion
Common Stock
2013-12-23$21.73/sh+3,000$65,190→ 3,750 total - Exercise/Conversion
Stock Options
2013-12-23−3,000→ 0 totalExercise: $21.73Exp: 2014-05-20→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 10, 2013
- [F2]On May 20, 2004, the Reporting Person received a grant of 3,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 2% each month thereafter. As of the date of this filing, 3,000 stock options have vested.